Guardant Health Q2 Adj. EPS $(0.44) Beats $(0.79) Estimate, Sales $232.09M Beat $211.26M Estimate

Benzinga07-31

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.79) by 44.51 percent. This is a 8.33 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $232.09 million which beat the analyst consensus estimate of $211.26 million by 9.86 percent. This is a 30.95 percent increase over sales of $177.24 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法